Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of VENUS REMEDIES. For more details, see the VENUS REMEDIES quarterly results and VENUS REMEDIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.9 |
No. of shares | m | 13.37 |
1 Week | % | 2.8 |
1 Month | % | 4.1 |
1 Year | % | 67.0 |
52 week H/L | Rs | 429.6/185.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VENUS REMEDIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 82 | 37 | 314 | 639 | 379 | |
Low | Rs | 29 | 20 | 22 | 261 | 145 | |
Sales per share (Unadj.) | Rs | 260.9 | 275.0 | 444.2 | 448.9 | 415.5 | |
Earnings per share (Unadj.) | Rs | -23.2 | -8.1 | 50.1 | 30.5 | 19.9 | |
Diluted earnings per share | Rs | -21.4 | -7.5 | 46.2 | 30.5 | 19.9 | |
Cash flow per share (Unadj.) | Rs | 4.4 | 17.8 | 78.6 | 55.5 | 44.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 269.5 | 262.1 | 313.2 | 329.4 | 344.3 | |
Adj. book value per share | Rs | 248.8 | 241.9 | 289.2 | 329.5 | 344.4 | |
Shares outstanding (eoy) | m | 12.34 | 12.34 | 12.34 | 13.37 | 13.37 | |
Price / Sales ratio | x | 0.2 | 0.1 | 0.4 | 1.0 | 0.6 | |
Avg P/E ratio | x | -2.4 | -3.5 | 3.4 | 14.8 | 13.2 | |
P/CF ratio (eoy) | x | 12.7 | 1.6 | 2.1 | 8.1 | 5.9 | |
Price / Book Value ratio | x | 0.2 | 0.1 | 0.5 | 1.4 | 0.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 684 | 351 | 2,075 | 6,011 | 3,501 | |
Total wages/salary | Rs m | 421 | 460 | 460 | 523 | 570 |
VENUS REMEDIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,219 | 3,393 | 5,481 | 6,002 | 5,555 | |
Other income | Rs m | 61 | 53 | 196 | 83 | 103 | |
Total revenues | Rs m | 3,280 | 3,446 | 5,678 | 6,085 | 5,658 | |
Gross profit | Rs m | 236 | 320 | 772 | 621 | 602 | |
Depreciation | Rs m | 340 | 320 | 353 | 335 | 323 | |
Interest | Rs m | 254 | 133 | 130 | 5 | 3 | |
Profit before tax | Rs m | -297 | -80 | 486 | 364 | 379 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -12 | 20 | -132 | -43 | 114 | |
Profit after tax | Rs m | -286 | -100 | 618 | 407 | 266 | |
Gross profit margin | % | 7.3 | 9.4 | 14.1 | 10.3 | 10.8 | |
Effective tax rate | % | 3.9 | -24.4 | -27.2 | -11.9 | 30.0 | |
Net profit margin | % | -8.9 | -2.9 | 11.3 | 6.8 | 4.8 |
VENUS REMEDIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,654 | 2,940 | 2,340 | 2,780 | 3,230 | |
Current liabilities | Rs m | 2,636 | 2,246 | 974 | 927 | 826 | |
Net working cap to sales | % | 0.6 | 20.5 | 24.9 | 30.9 | 43.3 | |
Current ratio | x | 1.0 | 1.3 | 2.4 | 3.0 | 3.9 | |
Inventory Days | Days | 43 | 38 | 23 | 21 | 37 | |
Debtors Days | Days | 431 | 330 | 213 | 235 | 504 | |
Net fixed assets | Rs m | 4,674 | 3,498 | 3,218 | 3,011 | 2,781 | |
Share capital | Rs m | 123 | 123 | 123 | 134 | 134 | |
"Free" reserves | Rs m | 3,202 | 3,110 | 3,742 | 4,271 | 4,470 | |
Net worth | Rs m | 3,325 | 3,234 | 3,865 | 4,404 | 4,603 | |
Long term debt | Rs m | 1,160 | 721 | 468 | 387 | 387 | |
Total assets | Rs m | 7,328 | 6,438 | 5,559 | 5,791 | 6,011 | |
Interest coverage | x | -0.2 | 0.4 | 4.7 | 76.7 | 130.0 | |
Debt to equity ratio | x | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.4 | 0.5 | 1.0 | 1.0 | 0.9 | |
Return on assets | % | -0.4 | 0.5 | 13.5 | 7.1 | 4.5 | |
Return on equity | % | -8.6 | -3.1 | 16.0 | 9.2 | 5.8 | |
Return on capital | % | -1.0 | 1.3 | 14.2 | 7.7 | 7.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
VENUS REMEDIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 453 | 776 | 1,318 | 411 | 366 | |
From Investments | Rs m | -113 | -47 | 565 | -167 | -508 | |
From Financial Activity | Rs m | -352 | -730 | -1,622 | -95 | -6 | |
Net Cashflow | Rs m | -12 | -1 | 269 | 144 | -220 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Pawan Chaudhary | COMP SEC: Neha Kodan | YEAR OF INC: 1989 | BSE CODE: 526953 | FV (Rs): 10 | DIV YIELD (%): - |
Read: VENUS REMEDIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare VENUS REMEDIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.